About Precision Medicine Group
Precision Medicine Group is a Healthcare company based in Bethesda (United States) founded in 2012 by Mark Clein. Provider of clinical research, development, and commercialization services for life sciences. Precision Medicine Group has raised $257.21 million across 4 funding rounds from investors including Blackstone, TPG and J.H. Whitney Capital Partners. The company has 2,151 employees. Precision Medicine Group has completed 13 acquisitions, including Agility Clinical, Algorics and ApoCell. Its chief executive, as recorded, is Mark Clein. Precision Medicine Group offers products and services including Biomarker Intelligence, Global CRO, and Specialty Labs. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity is Precision Medicine Group, LLC. Its competitors include Charles River Laboratories, Cytel and LabCorp; 1 of its 3 listed competitors has raised funding.
Company details
Precision Medicine Group was founded in 2012 and is headquartered in Bethesda, United States. Operations focus on the life sciences sector, where clinical research, biomarker-driven development, and commercialization services are delivered from product launch to maturity. Offerings include clinical development, specialty labs, commercial consulting, market access, and medical communications. Expertise in lab sciences, translational informatics, regulatory affairs, payer insights, and marketing communications is integrated across services.
- Headquarters Bethesda, United States
- Employees 2,151
- Founders Mark Clein
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website precisionmedicinegrp.com
- Social LinkedIn X
- Legal Name Precision Medicine Group, Llc
- Total Equity Funding$257.21M (USD)
in 4 rounds
- InvestorsBlackstone
& 5 more
- Employee Count2,151
- Investments & AcquisitionsAgility Clinical
& 12 more
Products & Services of Precision Medicine Group
Precision Medicine Group offers a comprehensive portfolio of products and services, including Biomarker Intelligence, Global CRO, and Specialty Labs.
Offers data analysis for biomarker-driven drug development processes.
Provides contract research for global clinical trials and studies.
Delivers central lab and biospecimen management for research needs.
Funding Insights of Precision Medicine Group
Precision Medicine Group has successfully raised a total of $257.21M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $257.21M
- Total Rounds 4
- First Round $150M
(Apr 2013)
- Investors Count 6
All 4 funding rounds of Precision Medicine Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | Private Equity Round | – | Blackstone | – | |
| Feb 2019 | $32.21M | Private Equity Round | – | – | – |
| Dec 2015 | $75M | Private Equity Round | – | TPG | – |
| Apr 2013 | $150M | Private Equity Round | – | J.H. Whitney Capital Partners, Oak Investment Partners |
6 investors in total: 4 institutional and 2 angel.
Investors in Precision Medicine Group
Precision Medicine Group has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Blackstone, TPG and J.H. Whitney Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States | |
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
| whitney.com | ||||
Venture capital investments are made in disruptive growth companies. | oakvc.com | Greenwich, United States | ||
ED Ethan D. Leder | unknown_f020121614674806b | |||
MP Mark P. Clein | unknown_240b163e487341039 |
Investor details for Precision Medicine Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Precision Medicine Group
36 people are tracked at Precision Medicine Group (22 in leadership, 14 in team); the tracked headcount is 2,151.
| Name | Role | Group |
|---|---|---|
Mark Clein | Co-Founder & Co-CEO | Leadership |
Margaret Keegan | Co-CEO | Leadership |
Karl Deonanan | Chief Financial Officer | Leadership |
Eric Hodgins | Chief Information Technology Officer | Leadership |
Chad Clark | President And Chief Operating Officer | Leadership |
Craig Natale | Vp, Global Talent Acquisition | Leadership |
Kevin Roach | VP Global Operations & Infrastructure | Leadership |
Tracey Leahy | Chief People Officer | Leadership |
Justin Clavell | Sr. Director Of Business Systems | Leadership |
Scott von Bargen | Senior Director Of Organizational Development And Learning | Leadership |
Barb Hoff | Senior Vice President, PMO & IT Governance | Leadership |
Bill Theofilou | Managing Partner, Axia Ventures | Leadership |
Chris Hadley | Managing Director, Berkshire Partners | Leadership |
Matt Hobart | Co-managing Partner, TPG Growth | Leadership |
Stacey J Hanna | Senior Vice President General Counsel And Chief Compliance Officer | Leadership |
Ameera Richards | Associate Director, People Analytics Amd HRIS | Leadership |
Karen Chiappetta | Vice President, Global Talent Acquisition | Leadership |
Bridget Watson Duffy | Vp, Strategic Business Development - Products | Leadership |
Jill Fitzsimmons | Director, Human Resources Business Partner | Leadership |
Stacie C. | Vice President, Global People Operations | Leadership |
16 more people are available in the full profile.
Complete people profiles for Precision Medicine Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Precision Medicine Group
Precision Medicine Group has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Agility Clinical, Algorics and ApoCell.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Platform for data analytics and risk management for clinical trials | algorics.com | Bengaluru, India | 2013 | May 2024 | •••• | |
Provider of consulting, quality, regulatory, and marketing services to biopharma sector | projectfarma.com | Bethesda, United States | 2013 | Jan 2021 | •••• | |
In-silico biomarker discovery and ranking services are provided for bioinformatics. | simplicitybio.com | Monthey, Switzerland | 2013 | Mar 2019 | •••• | |
Precision AQ is engaged in providing healthcare access and commercialization solutions. | sternir.com | New York, United States | 1998 | Dec 2018 | •••• | |
Provider of clinical trial and clinical development on bioanalytical services | apocell.com | Houston, United States | 2004 | Oct 2018 | •••• | |
Full-service regional CRO offering its services mainly to small and medium sized pharma and biotech companies | argintinternational.com | Budapest, Hungary | 2006 | Sep 2018 | •••• | |
Provider of digital marketing, data solutions, and medical affair solutions for pharmaceutical industry | ethoshc.com | Heywood, United Kingdom | 2013 | Jul 2018 | •••• | |
Provider of branding, content marketing, and website development services | bigpink.co.uk | Windsor, United Kingdom | 1992 | Apr 2018 | •••• | |
Strategy consulting is provided for pharma and biopharma sectors. | insightstrategyadvisors.com | New York, United States | 2002 | Jan 2018 | •••• | |
Biomarker data from clinical trials is analyzed by Quartz Bio. | quartz.bio | Geneva, Switzerland | 2012 | Jan 2018 | •••• |
Complete acquisition details for Precision Medicine Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Precision Medicine Group
13 dated milestones of Precision Medicine Group across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Precision Medicine Group is founded.
- Funding First funding round of $150.0M.
- Acquisition Acquires Quartz Bio.
- Acquisition Acquires Insight Strategy Advisors.
- Acquisition Acquires Big Pink.
- Acquisition Acquires Ethos Communication.
- Acquisition Acquires Argint International.
- Acquisition Acquires ApoCell.
- Acquisition Acquires Precision AQ.
- Acquisition Acquires SimplicityBio.
- Funding Latest funding round, Private Equity Round,.
- Acquisition Acquires Project Farma.
- Acquisition Acquires Algorics.
Competitors of Precision Medicine Group
Precision Medicine Group has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, Cytel and LabCorp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | 21,400 | Provider of drug discovery and preclinical development services | ||
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | 9,321 | Provider of laboratory tests for physicians |
Detailed competitors of Precision Medicine Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Precision Medicine Group
The website of Precision Medicine Group (precisionmedicinegrp.com) receives about 9.5K visits a month and ranks #2,514,688 among all websites worldwide, #3,454 in Biotechnology and Pharmaceuticals.
- Monthly visits9.5K
▼ 3.2% vs previous month
- Unique visitors5.2K
per month
- Global rank#2,514,688
among all websites
- Category rank#3,454
Health · Biotechnology and Pharmaceuticals
- Bounce rate52%
- Pages per visit1.3
- Average visit4 sec
- DevicesDesktop 50% · Mobile 50%
Websites whose visitors overlap most with Precision Medicine Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| precisionformedicine.com | 100% | 36.8K | #1,000,701 | View details | |
| sciphermedicine.com | 76% | 2.2K | #4,852,187 | View details | |
pharmavoice.com | pharmavoice.com | 76% | #720,985 | – | |
| reprocell.com | 61% | 37.7K | #846,797 | View details | |
| healthadvances.com | 56% | 14.2K | #1,881,077 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Precision Medicine Group
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Precision Medicine Group (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Precision Medicine Group
Complete news archive for Precision Medicine Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precision Medicine Group
Precision Medicine Group was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Precision Medicine Group is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Mark Clein is the CEO of Precision Medicine Group, as recorded in our data. They have also founded this company.
Precision Medicine Group is a funded company, having raised a total of $257.21M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $150M, raised on Apr 2013.
Precision Medicine Group has 2,151 employees.
Precision Medicine Group was founded in 2012 and is headquartered in Bethesda, United States. Operations focus on the life sciences sector, where clinical research, biomarker-driven development, and commercialization services are delivered from product launch to maturity. Offerings include clinical development, specialty labs, commercial consulting, market access, and medical communications. Expertise in lab sciences, translational informatics, regulatory affairs, payer insights, and marketing communications is integrated across services.
Precision Medicine Group's top competitors include LabCorp, Charles River Laboratories and Cytel.
Precision Medicine Group offers Biomarker Intelligence, Global CRO, and Specialty Labs.
Precision Medicine Group has made 13 acquisitions, including Agility Clinical, Algorics, and ApoCell.
Precision Medicine Group has 6 investors. Key investors include Blackstone, TPG, J.H. Whitney Capital Partners, Oak Investment Partners, and Ethan D. Leder.
Precision Medicine Group operates through Precision Medicine Group, Llc.